rs1212853305
- chr7-117501747-CAAAAAAAAAAAAAAAA-C
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAATTAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr7-117501747-CAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAATAAAAAAAAAAAAAAAAA
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000492.4(CFTR):c.54-2497_54-2482delAAAAAAAAAAAAAAAA variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000492.4 intron
Scores
Clinical Significance
Conservation
Publications
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CFTR | NM_000492.4 | MANE Select | c.54-2497_54-2482delAAAAAAAAAAAAAAAA | intron | N/A | NP_000483.3 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CFTR | ENST00000003084.11 | TSL:1 MANE Select | c.54-2505_54-2490delAAAAAAAAAAAAAAAA | intron | N/A | ENSP00000003084.6 | P13569-1 | ||
| CFTR | ENST00000546407.1 | TSL:1 | n.167-2505_167-2490delAAAAAAAAAAAAAAAA | intron | N/A | ||||
| CFTR | ENST00000699602.1 | c.54-2505_54-2490delAAAAAAAAAAAAAAAA | intron | N/A | ENSP00000514471.1 | A0A8V8TNH2 |
Frequencies
GnomAD3 genomes AF: 0.000137 AC: 6AN: 43902Hom.: 0 Cov.: 0 show subpopulations
GnomAD4 genome AF: 0.000137 AC: 6AN: 43902Hom.: 0 Cov.: 0 AF XY: 0.000102 AC XY: 2AN XY: 19670 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at